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SUMMARY:
A seroepidemiological study on human parvovirus (B19) in Japan was undertaken with serum samples randomly collected from healthy Japanese populations (416 in 1973, 675 in 1984 and 508 in 1987/88). All samples were tested for anti-B19 IgG antibody by the indirect antigen-capture ELISA . The antibody prevalence for ages 0-9 years old in 1984 was significantly higher (16%) than that in 1973 (2%), whereas those for ages 20-29 years and 30-39 years were significantly lower in 1984 (20% and 56%) than in 1973 (67% and 80%) (p<0.005).
After the erythema infectiosum (EI) outbreak in 1986/87, the antibody prevalences for ages 5-9, 10-14 and 15-19 years were 40-85% in Fukuoka, 0-10% in Gunma, and 21-41% in Chiba reflecting each EI incidence in these three prefectures, whereas those for ages 20-29 years remained low (<20%) . These data indicate that B19 virus was transmitted mainly among children and no significant incidence of B19 virus infection in adults has occurred since 1973 , resulting in a notable shifting of B19 susceptibility toward older ages including child-bearing females.
INTRODUCTION
In Japan, local epidemics of erythema infectiosum (EI) were first reported in the end of 1930's, followed by large epidemics with about ten-year cycles after (Fig. 2) . The mean prevalence rate of the age 0 group (18%) was higher than that of age 1 (8%), the former probably representing true incidence plus maternally acquired antibody, since four of five antibody-positive infants were under 3 months of age and one was 7 months old. At ages 1 through 4, there was no increase in incidence: the mean prevalence rate was 8%. But it increased at age 5 and kept an almost the same level (14-22%) at ages 6 through 9,10-14,15-19 and 20-24. Then, it slightly increased (25%) at ages 25-29, followed by a gradual increase up to 97% at ages 55-59. Secondly, the 1973-collection was compared retrospectively with the 1984 result. In younger age groups, there was a low prevalence of antibody: only one of 68 cases under 10 years of age was positive and the prevalence rate for age group 10-19 was 16%. The antibody prevalence remarkably increased to 67% at 20-29 years of age and retained at a high level (78-91%) in the older age groups. When the data were combined with those of the 10-year age groups (Fig . 3 ), significant differences in the prevalence rates between 1973 and 1984 were observed in the three age groups: 0-9 years (p<0.005), 20-29 years (p<0.001) and 30-39 years (p<0.005). Lastly, the 1987/88-collection was examined to compare the antibody prevalence in different parts of Japan after the 1986/87 EI epidemic (Fig. 4) . The prevalence in Fukuoka Prefecture (the large-epidemic area) was greater than that in Gunma Prefecture (the small-epidemic area) and the difference was In those studies, the techniques used were CIE, antibody-capture radioimmunoassay or antibody-capture ELISA. We applied the indirect antibodycapture ELISA system to anti-B19 IgG antibody assay. In the experiment of the ELISA standardization (Fig. 1 were obtained from older persons (32, 35, 44, 49 and 63 years old). We supposed that those people were exposed to B19 infection a long time ago, perhaps in childhood, and had escaped from reinfection which is thought to be the chance necessary to boost their antibody level. Although we did not compare ELISA with CIE using the same serum collection, we observed a significantly higher prevalence of ELISA-antibody for older age groups in Fukuoka Prefecture in 1984 than previously reported B19 antibody prevalence measured by CIE in the same area and same year (7): for ages older than 30, 58-90% by ELISA and 32-55% by CIE. But the antibody prevalence rates in the age groups under 30 were almost the same in ELISA and CIE assays. We supposed that the antibody present in samples from older individuals showing low positive DOD values by ELISA could not be detected by CIE assay.
The study on the age-specific prevalences of anti-B19 antibody in the representative serum collection in Japan demonstrated that the antibody-positive rate was as low as 20% or lower in young age groups but it remarkably increased in middle ages and reached a high level (>80%) in older age groups (Fig. 3) . There remained a large number of susceptibles in these child-bearing-age groups. The high prevalences in adults were reported in the previous cross-sectional studies (8, 9) and it was supposed that frequent asymptomatic infections with B19 occurred in adults as well as in children (12) .
But, our time-comparative data suggest that asymptomatic B19 infection in adults was not so frequent as in children, if any. High prevalence in older people may suggest the pre-existence of B19 outbreaks in their childhood.
Our IgG ELISA with the monoclonal antibody was found to be very convenient and useful for seroepidemiology of B19 virus infection and can be used for antibody screening of women who are at increased risk of B19 infection from children at their places of work or at home to provide recommendations for prevention in pregnancy.
